Table 1.
miRNA | Number of CRC Patients* |
Sample Type | Exosome Isolation Method |
Expression | Type of Biomarker | Refs |
---|---|---|---|---|---|---|
miR-16, miR-23a-3p, miR-23b-3p, miR-27a-3p, miR-27b-3p, miR-30b, miR-30c, and miR-222 |
13 | Serum and plasma | Ultracentrifugation | Upregulated | Diagnostic | [85] |
miR-96 and miR-149 |
102 | plasma | ExoCapTM exosome isolation and enrichment kit | downregulated | Diagnostic | [87] |
miR-23a and miR-301a | 25 | serum | ExoQuick | upregulated | Diagnostic | [91] |
miR-17, miR-181a, miR-18a, and miR-18b |
18 | plasma | ExoQuick | upregulated | diagnostic | [90] |
miR-320d | 142 | serum | ultracentrifugation | upregulated | Diagnostic | [92] |
miR-125a and miR-320c | 50 | plasma | ExoQuick | upregulated | Diagnostic | [89] |
miR-92b | 40 | plasma | ultracentrifugation | downregulated | Diagnostic | [88] |
let-7a, miR-1229, miR-1246, miR-150, miR-21, miR-223, and miR-23a | 88 | serum | ultracentrifugation | upregulated | Diagnostic | [93] |
miR-6869 | 142 | serum | Invitrogen Total Exosome Isolation Kit | downregulated | Prognostic | [94] |
miR-146a | 53 | serum | Ultracentrifugation, ExoQuick |
upregulated | Prognostic | [95] |
miR-1229 | 97 | serum | ultracentrifugation | upregulated | Prognostic | [96] |
miR-19a | 227 | serum | Invitrogen Total Exosome Isolation Kit | upregulated | Prognostic | [97] |
miR-21 | 326 | plasma | ultracentrifugation | Upregulated | Prognostic | [98] |
miR-25-3p | 75 | serum | ultracentrifugation | upregulated | Prognostic | [99] |
miR-4772-3p | 84 | serum | ExoQuick | downregulated | Prognostic | [100] |
miR-17, miR-18a, miR-18b, miR-19a, miR-19b, miR-20a, miR-20b and miR-106a | 100 | plasma | ExoQuick | upregulated | Prognostic | [101] |
miR-193a | 25 | plasma | Ultracentrifugation, exoEasy Maxi Kit |
upregulated | Prognostic | [102] |
miR-17 and miR-92a-3p | 29 | serum | Ultracentrifugation and qEV Size Exclusion Columns | upregulated | Prognostic | [103] |
miR-203 | 240 | serum | ultracentrifugation | upregulated | Prognostic | [104] |
miR-21, miR-1246, miR-1229, and miR-96 |
43 | serum | Ultracentrifugation, Invitrogen Total Exosome Isolation Kit, western blot | upregulated | Predictive | [105] |
miR-548c | 108 | serum | Invitrogen Total Exosome Isolation Kit | downregulated | Diagnostic and Prognostic | [106] |
miR-27a and miR-130a | 369 | plasma | Invitrogen Total Exosome Isolation Kit | upregulated | Diagnostic and Prognostic | [107] |
miR-6803 | 168 | serum | Invitrogen Total Exosome Isolation Kit | upregulated | Diagnostic and Prognostic | [108] |
miR-221 | 158 | serum | Ultracentrifugation | upregulated | Diagnostic and Prognostic | [109] |
miR-150 | 133 | serum | ExoQuick | downregulated | Diagnostic and Prognostic | [110] |
miR-196b | 150 | serum | exoRNeasy Serum/Plasma Maxi Kit | upregulated | Prognostic, and Predictive | [111] |
miR-125b | 61 | plasma | ultracentrifugation | upregulated | Prognostic, and predictive | [112] |
* number of CRC patients who had blood samples drawn which were utilized for exosomal analysis.